Eastman Chemical Company (EMN)
NYSE: EMN · Real-Time Price · USD
68.17
+0.89 (1.32%)
Jul 30, 2026, 1:19 PM EDT - Market open
Eastman Chemical Company Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 665 | 566 | 837 | 548 | 493 | 459 |
Cash & Short-Term Investments | 665 | 566 | 837 | 548 | 493 | 459 |
Cash Growth | 59.09% | -32.38% | 52.74% | 11.16% | 7.41% | -18.62% |
Accounts Receivable | 949 | 737 | 791 | 826 | 957 | 1,091 |
Other Receivables | 268 | 262 | 381 | 328 | 320 | 489 |
Total Trade Receivables | 1,217 | 999 | 1,172 | 1,154 | 1,277 | 1,580 |
Inventory | 2,078 | 1,980 | 1,988 | 1,683 | 1,894 | 1,504 |
Other Current Assets | 96 | 100 | 104 | 96 | 114 | 1,103 |
Total Current Assets | 4,056 | 3,645 | 4,101 | 3,481 | 3,778 | 4,646 |
Net Property, Plant & Equipment | 5,687 | 5,731 | 5,615 | 5,548 | 5,160 | 4,996 |
Other Intangible Assets | 946 | 970 | 1,032 | 1,138 | 1,210 | 1,362 |
Goodwill | 3,662 | 3,665 | 3,632 | 3,646 | 3,664 | 3,641 |
Other Long-Term Assets | 871 | 848 | 833 | 820 | 855 | 874 |
Total Assets | 15,222 | 14,859 | 15,213 | 14,633 | 14,667 | 15,519 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Short-Term Debt | 770 | 586 | 450 | 541 | 1,126 | 747 |
Other Current Liabilities | 1,998 | 2,066 | 2,258 | 2,035 | 2,125 | 2,224 |
Total Current Liabilities | 2,768 | 2,652 | 2,708 | 2,576 | 3,251 | 2,971 |
Long-Term Debt | 4,450 | 4,201 | 4,567 | 4,305 | 4,025 | 4,412 |
Other Long-Term Liabilities | 1,918 | 1,969 | 2,086 | 2,222 | 2,155 | 2,348 |
Total Long-Term Liabilities | 6,368 | 6,170 | 6,653 | 6,527 | 6,180 | 6,760 |
Total Liabilities | 9,136 | 8,822 | 9,361 | 9,103 | 9,431 | 9,731 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 2 | 2 | 2 | 2 | 2 | 2 |
Treasury Stock | -6,486 | -6,486 | -6,385 | -6,083 | -5,932 | -4,860 |
Additional Paid-in Capital | 2,520 | 2,500 | 2,463 | 2,368 | 2,315 | 2,187 |
Accumulated Other Comprehensive Income | -141 | -160 | -314 | -319 | -205 | -182 |
Retained Earnings | 10,114 | 10,105 | 10,013 | 9,490 | 8,973 | 8,557 |
Total Common Shareholders' Equity | 6,009 | 5,961 | 5,779 | 5,458 | 5,153 | 5,704 |
Minority Interest | 77 | 76 | 73 | 72 | 83 | 84 |
Shareholders' Equity | 6,086 | 6,037 | 5,852 | 5,530 | 5,236 | 5,788 |
Total Liabilities & Equity | 15,222 | 14,859 | 15,213 | 14,633 | 14,667 | 15,519 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 5,220 | 4,787 | 5,017 | 4,846 | 5,151 | 5,159 |
Net Cash (Debt) | -4,555 | -4,221 | -4,180 | -4,298 | -4,658 | -4,700 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -39.48 | -36.51 | -35.45 | -36.00 | -37.29 | -34.28 |
Book Value | 6,009 | 5,961 | 5,779 | 5,458 | 5,153 | 5,704 |
Book Value Per Share | 52.08 | 51.57 | 49.02 | 45.71 | 41.26 | 41.60 |
Tangible Book Value | 1,401 | 1,326 | 1,115 | 674 | 279 | 701 |
Tangible Book Value Per Share | 12.14 | 11.47 | 9.46 | 5.64 | 2.23 | 5.11 |